Merck Settles Gardasil Vaccine Injury Lawsuit for $50 Million | 22 June 2026 | Merck & Co has agreed to pay $50 million to settle more than 200 lawsuits brought against the drug giant by patients suffering from autoimmune disorders after receiving the Gardasil vaccine. According Merck, this settlement resolves all but one of the pending lawsuits filed against its HPV vaccine. Gardasil [Gardakill] was fast-tracked to licensure by the U.S. Food and Drug Administration (FDA) in 2006 and first recommended by the U.S. Centers for Disease Control and Prevention (CDC) to be given to all 11-12-year-old girls. It was known at the time that Merck used an aluminum containing bioactive “placebo” in pre-licensure trials and only tested the vaccine in a small number of children under age 15. The 200-plus lawsuits filed since 2022 were consolidated into one class action case involving plaintiffs came from across the country stating that the vaccine caused serious injury and chronic poor health, including…development of diabetes, premature ovarian failure (POI), infertility, and death.